Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients

Background: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA‐100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we dete...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2011-05, Vol.9 (5), p.953-958
Hauptverfasser: HOLLESTELLE, M. J., LOOTS, C. M., SQUIZZATO, A., RENNÉ, T., BOUMA, B. J., DE GROOT, P. G., LENTING, P. J., MEIJERS, J. C. M., GERDES, V. E. A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 958
container_issue 5
container_start_page 953
container_title JOURNAL OF THROMBOSIS AND HAEMOSTASIS
container_volume 9
creator HOLLESTELLE, M. J.
LOOTS, C. M.
SQUIZZATO, A.
RENNÉ, T.
BOUMA, B. J.
DE GROOT, P. G.
LENTING, P. J.
MEIJERS, J. C. M.
GERDES, V. E. A.
description Background: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA‐100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we determined the level of VWF in its active, platelet‐binding conformation in plasma of patients with aortic stenosis. Patients/methods: Sixty‐two aortic stenosis patients were included in this study. VWF and related parameters were measured, and the results were related to severity of aortic stenosis. Results: VWF activation factor, indicating the proportion of circulating VWF able to bind to platelets, correlated negatively with peak transvalvular gradient and PFA‐100 closure time. No correlation was observed between ADAMTS13 activity and peak transvalvular gradient or PFA‐100 closure time. Both VWF antigen and VWF propeptide levels were significantly higher in patients with mild and moderate aortic stenosis, but not in those with severe stenosis. Conclusions: Our data demonstrate that the aortic pressure gradient is inversely associated with VWF activation factor, but not with VWF antigen or VWF multimerization in patients with aortic stenosis. These findings might have implications for the bleeding observed in patients with aortic stenosis.
doi_str_mv 10.1111/j.1538-7836.2011.04247.x
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_swepub_primary_oai_swepub_ki_se_545921</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3834850751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4527-fa14564a4cc5b6f8d4451feb796c3d33b4aeb2d4a6c55d0d187716aeb0ad93d43</originalsourceid><addsrcrecordid>eNqNUc1u3CAYRFWqJtn0FSKknO2CAWMfeqg2aTdVpF626i0Iw-eEjdc44P3J2xd3N3suF0bDfAPMIIQpyWlaX1Y5FazKZMXKvCCU5oQXXOb7D-jidHD2jmvGztFljCtCaC0K8gmdF5SJgpf1BXq8BRNAR7BYm9FtAW99j_-4roMm6N7iNtE-4A620GG_c_0THj2Oz6ADjmOAGLHrsfZhdCYR0PvoIh706KAf4xX62OouwufjPkO_v98t54vs4deP-_m3h8xwUcis1ZSLkmtujGjKtrKcC9pCI-vSMMtYwzU0heW6NEJYYmklJS0TR7StmeVshrKDb9zBsGnUENxahzfltVNH6iUhUIKLOv1-hm4O-iH41w3EUa38JvTpiYrKgsqaSzm5VgeVCT7GAO3JlxI1FaFWaspYTXmrqQj1rwi1T6PXxws2zRrsafA9-ST4ehDsXAdv_22sfi4XE2J_ATX2mJU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1721794774</pqid></control><display><type>article</type><title>Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>SWEPUB Freely available online</source><creator>HOLLESTELLE, M. J. ; LOOTS, C. M. ; SQUIZZATO, A. ; RENNÉ, T. ; BOUMA, B. J. ; DE GROOT, P. G. ; LENTING, P. J. ; MEIJERS, J. C. M. ; GERDES, V. E. A.</creator><creatorcontrib>HOLLESTELLE, M. J. ; LOOTS, C. M. ; SQUIZZATO, A. ; RENNÉ, T. ; BOUMA, B. J. ; DE GROOT, P. G. ; LENTING, P. J. ; MEIJERS, J. C. M. ; GERDES, V. E. A.</creatorcontrib><description>Background: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA‐100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we determined the level of VWF in its active, platelet‐binding conformation in plasma of patients with aortic stenosis. Patients/methods: Sixty‐two aortic stenosis patients were included in this study. VWF and related parameters were measured, and the results were related to severity of aortic stenosis. Results: VWF activation factor, indicating the proportion of circulating VWF able to bind to platelets, correlated negatively with peak transvalvular gradient and PFA‐100 closure time. No correlation was observed between ADAMTS13 activity and peak transvalvular gradient or PFA‐100 closure time. Both VWF antigen and VWF propeptide levels were significantly higher in patients with mild and moderate aortic stenosis, but not in those with severe stenosis. Conclusions: Our data demonstrate that the aortic pressure gradient is inversely associated with VWF activation factor, but not with VWF antigen or VWF multimerization in patients with aortic stenosis. These findings might have implications for the bleeding observed in patients with aortic stenosis.</description><identifier>ISSN: 1538-7933</identifier><identifier>ISSN: 1538-7836</identifier><identifier>EISSN: 1538-7836</identifier><identifier>DOI: 10.1111/j.1538-7836.2011.04247.x</identifier><identifier>PMID: 21352469</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>ADAM Proteins - blood ; ADAMTS13 Protein ; Aged ; Antigens ; aortic stenosis ; Aortic Valve Stenosis - blood ; Aortic Valve Stenosis - pathology ; Cardiology ; Electrocardiography ; Female ; Hemorrhage ; Hemostasis ; Humans ; Male ; Middle Aged ; Peptides - chemistry ; platelet ; Platelet Function Tests ; Shear Strength ; Stress, Mechanical ; Surveys and Questionnaires ; von Willebrand factor ; von Willebrand Factor - biosynthesis ; von Willebrand factor propeptide</subject><ispartof>JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011-05, Vol.9 (5), p.953-958</ispartof><rights>2011 International Society on Thrombosis and Haemostasis</rights><rights>2011 International Society on Thrombosis and Haemostasis.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4527-fa14564a4cc5b6f8d4451feb796c3d33b4aeb2d4a6c55d0d187716aeb0ad93d43</citedby><cites>FETCH-LOGICAL-c4527-fa14564a4cc5b6f8d4451feb796c3d33b4aeb2d4a6c55d0d187716aeb0ad93d43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,550,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21352469$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:122554244$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>HOLLESTELLE, M. J.</creatorcontrib><creatorcontrib>LOOTS, C. M.</creatorcontrib><creatorcontrib>SQUIZZATO, A.</creatorcontrib><creatorcontrib>RENNÉ, T.</creatorcontrib><creatorcontrib>BOUMA, B. J.</creatorcontrib><creatorcontrib>DE GROOT, P. G.</creatorcontrib><creatorcontrib>LENTING, P. J.</creatorcontrib><creatorcontrib>MEIJERS, J. C. M.</creatorcontrib><creatorcontrib>GERDES, V. E. A.</creatorcontrib><title>Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients</title><title>JOURNAL OF THROMBOSIS AND HAEMOSTASIS</title><addtitle>J Thromb Haemost</addtitle><description>Background: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA‐100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we determined the level of VWF in its active, platelet‐binding conformation in plasma of patients with aortic stenosis. Patients/methods: Sixty‐two aortic stenosis patients were included in this study. VWF and related parameters were measured, and the results were related to severity of aortic stenosis. Results: VWF activation factor, indicating the proportion of circulating VWF able to bind to platelets, correlated negatively with peak transvalvular gradient and PFA‐100 closure time. No correlation was observed between ADAMTS13 activity and peak transvalvular gradient or PFA‐100 closure time. Both VWF antigen and VWF propeptide levels were significantly higher in patients with mild and moderate aortic stenosis, but not in those with severe stenosis. Conclusions: Our data demonstrate that the aortic pressure gradient is inversely associated with VWF activation factor, but not with VWF antigen or VWF multimerization in patients with aortic stenosis. These findings might have implications for the bleeding observed in patients with aortic stenosis.</description><subject>ADAM Proteins - blood</subject><subject>ADAMTS13 Protein</subject><subject>Aged</subject><subject>Antigens</subject><subject>aortic stenosis</subject><subject>Aortic Valve Stenosis - blood</subject><subject>Aortic Valve Stenosis - pathology</subject><subject>Cardiology</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Hemorrhage</subject><subject>Hemostasis</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Peptides - chemistry</subject><subject>platelet</subject><subject>Platelet Function Tests</subject><subject>Shear Strength</subject><subject>Stress, Mechanical</subject><subject>Surveys and Questionnaires</subject><subject>von Willebrand factor</subject><subject>von Willebrand Factor - biosynthesis</subject><subject>von Willebrand factor propeptide</subject><issn>1538-7933</issn><issn>1538-7836</issn><issn>1538-7836</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>D8T</sourceid><recordid>eNqNUc1u3CAYRFWqJtn0FSKknO2CAWMfeqg2aTdVpF626i0Iw-eEjdc44P3J2xd3N3suF0bDfAPMIIQpyWlaX1Y5FazKZMXKvCCU5oQXXOb7D-jidHD2jmvGztFljCtCaC0K8gmdF5SJgpf1BXq8BRNAR7BYm9FtAW99j_-4roMm6N7iNtE-4A620GG_c_0THj2Oz6ADjmOAGLHrsfZhdCYR0PvoIh706KAf4xX62OouwufjPkO_v98t54vs4deP-_m3h8xwUcis1ZSLkmtujGjKtrKcC9pCI-vSMMtYwzU0heW6NEJYYmklJS0TR7StmeVshrKDb9zBsGnUENxahzfltVNH6iUhUIKLOv1-hm4O-iH41w3EUa38JvTpiYrKgsqaSzm5VgeVCT7GAO3JlxI1FaFWaspYTXmrqQj1rwi1T6PXxws2zRrsafA9-ST4ehDsXAdv_22sfi4XE2J_ATX2mJU</recordid><startdate>201105</startdate><enddate>201105</enddate><creator>HOLLESTELLE, M. J.</creator><creator>LOOTS, C. M.</creator><creator>SQUIZZATO, A.</creator><creator>RENNÉ, T.</creator><creator>BOUMA, B. J.</creator><creator>DE GROOT, P. G.</creator><creator>LENTING, P. J.</creator><creator>MEIJERS, J. C. M.</creator><creator>GERDES, V. E. A.</creator><general>Blackwell Publishing Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>ZZAVC</scope></search><sort><creationdate>201105</creationdate><title>Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients</title><author>HOLLESTELLE, M. J. ; LOOTS, C. M. ; SQUIZZATO, A. ; RENNÉ, T. ; BOUMA, B. J. ; DE GROOT, P. G. ; LENTING, P. J. ; MEIJERS, J. C. M. ; GERDES, V. E. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4527-fa14564a4cc5b6f8d4451feb796c3d33b4aeb2d4a6c55d0d187716aeb0ad93d43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>ADAM Proteins - blood</topic><topic>ADAMTS13 Protein</topic><topic>Aged</topic><topic>Antigens</topic><topic>aortic stenosis</topic><topic>Aortic Valve Stenosis - blood</topic><topic>Aortic Valve Stenosis - pathology</topic><topic>Cardiology</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Hemorrhage</topic><topic>Hemostasis</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Peptides - chemistry</topic><topic>platelet</topic><topic>Platelet Function Tests</topic><topic>Shear Strength</topic><topic>Stress, Mechanical</topic><topic>Surveys and Questionnaires</topic><topic>von Willebrand factor</topic><topic>von Willebrand Factor - biosynthesis</topic><topic>von Willebrand factor propeptide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>HOLLESTELLE, M. J.</creatorcontrib><creatorcontrib>LOOTS, C. M.</creatorcontrib><creatorcontrib>SQUIZZATO, A.</creatorcontrib><creatorcontrib>RENNÉ, T.</creatorcontrib><creatorcontrib>BOUMA, B. J.</creatorcontrib><creatorcontrib>DE GROOT, P. G.</creatorcontrib><creatorcontrib>LENTING, P. J.</creatorcontrib><creatorcontrib>MEIJERS, J. C. M.</creatorcontrib><creatorcontrib>GERDES, V. E. A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SwePub Articles full text</collection><jtitle>JOURNAL OF THROMBOSIS AND HAEMOSTASIS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>HOLLESTELLE, M. J.</au><au>LOOTS, C. M.</au><au>SQUIZZATO, A.</au><au>RENNÉ, T.</au><au>BOUMA, B. J.</au><au>DE GROOT, P. G.</au><au>LENTING, P. J.</au><au>MEIJERS, J. C. M.</au><au>GERDES, V. E. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients</atitle><jtitle>JOURNAL OF THROMBOSIS AND HAEMOSTASIS</jtitle><addtitle>J Thromb Haemost</addtitle><date>2011-05</date><risdate>2011</risdate><volume>9</volume><issue>5</issue><spage>953</spage><epage>958</epage><pages>953-958</pages><issn>1538-7933</issn><issn>1538-7836</issn><eissn>1538-7836</eissn><abstract>Background: Aortic stenosis patients often show bleeding complications. Previously, a prolonged platelet function analyzer (PFA‐100) closure time was observed with plasma of severe aortic stenosis patients. To elucidate a possible role of circulating preactivated von Willebrand factor (VWF), we determined the level of VWF in its active, platelet‐binding conformation in plasma of patients with aortic stenosis. Patients/methods: Sixty‐two aortic stenosis patients were included in this study. VWF and related parameters were measured, and the results were related to severity of aortic stenosis. Results: VWF activation factor, indicating the proportion of circulating VWF able to bind to platelets, correlated negatively with peak transvalvular gradient and PFA‐100 closure time. No correlation was observed between ADAMTS13 activity and peak transvalvular gradient or PFA‐100 closure time. Both VWF antigen and VWF propeptide levels were significantly higher in patients with mild and moderate aortic stenosis, but not in those with severe stenosis. Conclusions: Our data demonstrate that the aortic pressure gradient is inversely associated with VWF activation factor, but not with VWF antigen or VWF multimerization in patients with aortic stenosis. These findings might have implications for the bleeding observed in patients with aortic stenosis.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21352469</pmid><doi>10.1111/j.1538-7836.2011.04247.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1538-7933
ispartof JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011-05, Vol.9 (5), p.953-958
issn 1538-7933
1538-7836
1538-7836
language eng
recordid cdi_swepub_primary_oai_swepub_ki_se_545921
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; SWEPUB Freely available online
subjects ADAM Proteins - blood
ADAMTS13 Protein
Aged
Antigens
aortic stenosis
Aortic Valve Stenosis - blood
Aortic Valve Stenosis - pathology
Cardiology
Electrocardiography
Female
Hemorrhage
Hemostasis
Humans
Male
Middle Aged
Peptides - chemistry
platelet
Platelet Function Tests
Shear Strength
Stress, Mechanical
Surveys and Questionnaires
von Willebrand factor
von Willebrand Factor - biosynthesis
von Willebrand factor propeptide
title Decreased active von Willebrand factor level owing to shear stress in aortic stenosis patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A09%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decreased%20active%20von%20Willebrand%20factor%20level%20owing%20to%20shear%20stress%20in%20aortic%20stenosis%20patients&rft.jtitle=JOURNAL%20OF%20THROMBOSIS%20AND%20HAEMOSTASIS&rft.au=HOLLESTELLE,%20M.%20J.&rft.date=2011-05&rft.volume=9&rft.issue=5&rft.spage=953&rft.epage=958&rft.pages=953-958&rft.issn=1538-7933&rft.eissn=1538-7836&rft_id=info:doi/10.1111/j.1538-7836.2011.04247.x&rft_dat=%3Cproquest_swepu%3E3834850751%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1721794774&rft_id=info:pmid/21352469&rfr_iscdi=true